Augmented efficacy of brentuximab vedotin combined with ruxolitinib and/or Navitoclax in a murine model of human Hodgkin’s lymphoma
Crossref DOI link: https://doi.org/10.1073/pnas.1524668113
Published Online: 2016-01-25
Published Print: 2016-02-09
Update policy: https://doi.org/10.1073/pnas.cm10313
Ju, Wei
Zhang, Meili
Wilson, Kelli M.
Petrus, Michael N.
Bamford, Richard N.
Zhang, Xiaohu
Guha, Rajarshi
Ferrer, Marc
Thomas, Craig J.
Waldmann, Thomas A.
Publication History
Published: 2016-01-25